Xenon Pharmaceuticals Inc. (XENE) NASDAQ

$43.05 0.05 (0.12%)

Market Cap: $3.24B

As of 03/28/24 04:00 PM EDT. Market closed.

(XENE)

Xenon Pharmaceuticals Inc. (XENE)
NASDAQ

$43.05
0.05 (0.12%)

Market Cap: $3.24B

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

xenon® (nasdaq: xene) is a biopharmaceutical company focused on the development of novel medicines through the application of our proprietary discovery platform, which we refer to as extreme genetics. our product candidates are based on genetic insights derived from our research of families where individuals exhibit severe traits, or phenotypes. we apply our expertise to predict which phenotypes ... read more

xenon® (nasdaq: xene) is a biopharmaceutical company focused on the development of novel medicines through the application of our proprietary discovery platform, which we refer to as extreme genetics. our product candidates are based on genetic insights derived from our research of families where individuals exhibit severe traits, or phenotypes. we apply our expertise to predict which phenotypes are caused by single-gene defects. by identifying and characterizing the single-gene defects responsible for such severe phenotypes, we gain valuable insights into their function in human biology and their potential as drug targets. given that these targets are often involved in diseases beyond the rare genetic disorders in which they are first identified, we are developing proprietary product candidates to treat both orphan as well as more prevalent diseases. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Simon Pimstone
Full Time Employees
236
URL
Address
3650 Gilmore Way, British Columbia, Burnaby, V5G 4W8.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Simon Pimstone
Full Time Employees
236
Address
3650 Gilmore Way, British Columbia, Burnaby, V5G 4W8.
PRICE CHART FOR XENON PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$42.67
Previous Close
$43
Days Range
$42.15 - $43.01
52 week range
$27.99 - $50.99
Volume
364,266
Avg. Volume (30 days)
380,134
Market Cap
$3.24B
Dividend Yield
-
P/E
(19.77)
Shares Outstanding
75,432,482
Open
$42.67
Previous Close
$43
Days Range
$42.15 - $43.01
52 week range
$27.99 - $50.99
Volume
364,266
Avg. Volume (30 days)
380,134
Market Cap
$3.24B
Dividend Yield
-
P/E
(19.77)
Shares Outstanding
75,432,482
FINANCIAL STATEMENTS FOR XENON PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR XENON PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
GAROFALO ELIZABETH A.DirectorMar 08, 2024 Option Exercise$46.161,40864,9932,092Mar 11, 2024, 08:09 PM
GAROFALO ELIZABETH A.DirectorMar 08, 2024 Option Exercise$18.563,50064,9603,500Mar 11, 2024, 08:09 PM
GAROFALO ELIZABETH A.DirectorMar 08, 2024 Sale$45.692,09295,5830Mar 11, 2024, 08:09 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationMar 07, 2024 Option Exercise$45.961,50469,12415,535Mar 08, 2024, 05:31 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationMar 07, 2024 Option Exercise$9.858,64185,11416,824Mar 08, 2024, 05:31 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationMar 07, 2024 Sale$46.287,137330,29014,516Mar 08, 2024, 05:31 PM
GANNON STEVENDirectorMar 07, 2024 Sale$46.2813,000601,61514,000Mar 08, 2024, 05:28 PM
AZAB MOHAMMADDirectorDec 19, 2023 Option Exercise$9.854,32042,55274,225Dec 20, 2023, 05:04 PM
PATOU GARYDirectorDec 14, 2023 Sale$41.057,598311,8984,902Dec 15, 2023, 09:50 PM
PATOU GARYDirectorDec 13, 2023 Option Exercise$39.683,022119,91328,673Dec 15, 2023, 05:38 PM
PATOU GARYDirectorDec 13, 2023 Option Exercise$9.5514,402137,48729,951Dec 15, 2023, 05:38 PM
PATOU GARYDirectorDec 13, 2023 Sale$41.057,598311,8984,902Dec 15, 2023, 05:38 PM
PATOU GARYDirectorDec 13, 2023 Sale$39.2911,380447,08523,573Dec 15, 2023, 05:38 PM
Svoronos DawnDirectorAug 24, 2023 Sale$38.7025,000967,50025,000Aug 24, 2023, 04:33 PM
PIMSTONE SIMON N.DirectorMay 31, 2023 Option Exercise$38.3729,3091,124,58632,856Jun 01, 2023, 07:25 PM
PIMSTONE SIMON N.DirectorJun 01, 2023 Option Exercise$38.5322,605870,97130,255Jun 01, 2023, 07:25 PM
PIMSTONE SIMON N.DirectorJun 01, 2023 Option Exercise$16.0354,318870,85551,000Jun 01, 2023, 07:25 PM
PIMSTONE SIMON N.DirectorMay 31, 2023 Option Exercise$14.8079,8351,181,87556,000Jun 01, 2023, 07:25 PM
PIMSTONE SIMON N.DirectorMay 31, 2023 Sale$38.7062,5262,420,0516,000Jun 01, 2023, 07:25 PM
PIMSTONE SIMON N.DirectorMay 30, 2023 Sale$39.2837,0061,453,67237,000Jun 01, 2023, 07:25 PM
PIMSTONE SIMON N.DirectorJun 01, 2023 Sale$38.8231,7131,231,2476,000Jun 01, 2023, 07:25 PM
MORTIMER IANPRESIDENT & CEOMay 24, 2023 Option Exercise$41.8412,383518,10541,282May 26, 2023, 07:10 PM
MORTIMER IANPRESIDENT & CEOMay 24, 2023 Option Exercise$9.6069,340665,53648,592May 26, 2023, 07:10 PM
MORTIMER IANPRESIDENT & CEOMay 24, 2023 Sale$41.4131,6551,310,93131,302May 26, 2023, 07:10 PM
KENNEY CHRISTOPHER JOHNChief Medical OfficerMar 24, 2023 Sale$35.0170024,5070Mar 24, 2023, 07:18 PM
PIMSTONE SIMON N.DirectorMar 07, 2023 Option Exercise$37.133,778140,27763,248Mar 09, 2023, 06:21 PM
PIMSTONE SIMON N.DirectorMar 07, 2023 Option Exercise$2.6472,016190,22564,866Mar 09, 2023, 06:21 PM
PIMSTONE SIMON N.DirectorMar 07, 2023 Sale$36.9819,232711,19955,006Mar 09, 2023, 06:21 PM
AZAB MOHAMMADDirectorDec 12, 2022 Option Exercise$2.683,0868,27069,905Dec 13, 2022, 04:29 PM
PATOU GARYDirectorNov 25, 2022 Option Exercise$34.371204,12425,510Nov 28, 2022, 08:41 PM
PATOU GARYDirectorNov 25, 2022 Option Exercise$2.682,0575,51325,630Nov 28, 2022, 08:41 PM
PATOU GARYDirectorNov 25, 2022 Sale$34.791,93767,39023,573Nov 28, 2022, 08:41 PM
PATOU GARYDirectorNov 23, 2022 Sale$34.332,05770,61023,573Nov 28, 2022, 08:41 PM
AULIN SHERRYChief Financial OfficerSep 02, 2022 Option Exercise$39.533,293130,17215,355Sep 07, 2022, 04:26 PM
AULIN SHERRYChief Financial OfficerSep 02, 2022 Option Exercise$6.9718,648130,06118,648Sep 07, 2022, 04:26 PM
AULIN SHERRYChief Financial OfficerSep 02, 2022 Sale$39.5715,355607,5970Sep 07, 2022, 04:26 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationSep 01, 2022 Option Exercise$38.816,121237,55660,675Sep 02, 2022, 04:27 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationAug 31, 2022 Option Exercise$37.861,57259,51638,148Sep 02, 2022, 04:27 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationAug 31, 2022 Option Exercise$3.1322,48870,44339,720Sep 02, 2022, 04:27 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationSep 01, 2022 Option Exercise$4.7550,000237,50066,796Sep 02, 2022, 04:27 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationSep 01, 2022 Sale$38.1843,8791,675,47625,572Sep 02, 2022, 04:27 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationAug 31, 2022 Sale$38.5721,352823,54716,796Sep 02, 2022, 04:27 PM
EMPFIELD JAMES R.EVP, Drug DiscoveryAug 12, 2022 Option Exercise$38.027,257275,91167,743Aug 16, 2022, 05:36 PM
EMPFIELD JAMES R.EVP, Drug DiscoveryAug 12, 2022 Option Exercise$4.2465,000275,75075,000Aug 16, 2022, 05:36 PM
EMPFIELD JAMES R.EVP, Drug DiscoveryAug 12, 2022 Sale$38.3157,7432,211,97931,875Aug 16, 2022, 05:36 PM
PIMSTONE SIMON N.DirectorAug 16, 2022 Sale$38.5152,0582,004,90126,000Aug 16, 2022, 05:31 PM
PIMSTONE SIMON N.DirectorAug 15, 2022 Sale$37.7633,9421,281,65058,058Aug 16, 2022, 05:31 PM
PIMSTONE SIMON N.DirectorAug 12, 2022 Sale$38.2891,1353,488,598140,000Aug 16, 2022, 05:31 PM
PIMSTONE SIMON N.DirectorMar 08, 2022 Sale$30.802,50077,000193,135Mar 08, 2022, 09:41 PM
PIMSTONE SIMON N.DirectorMar 04, 2022 Option Exercise$31.4296330,257219,511Mar 08, 2022, 07:58 PM
PIMSTONE SIMON N.DirectorMar 07, 2022 Option Exercise$30.231,99060,158228,772Mar 08, 2022, 07:58 PM
PIMSTONE SIMON N.DirectorMar 04, 2022 Option Exercise$3.6710,28837,757220,474Mar 08, 2022, 07:58 PM
PIMSTONE SIMON N.DirectorMar 07, 2022 Option Exercise$3.6720,57675,514230,762Mar 08, 2022, 07:58 PM
PIMSTONE SIMON N.DirectorMar 08, 2022 Sale$25.8214,551375,636195,635Mar 08, 2022, 07:58 PM
PIMSTONE SIMON N.DirectorMar 07, 2022 Sale$30.5031,086948,260223,735Mar 08, 2022, 07:58 PM
PIMSTONE SIMON N.DirectorMar 04, 2022 Sale$30.619,325285,425214,979Mar 08, 2022, 07:58 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationMar 04, 2022 Option Exercise$31.4269621,86832,770Mar 08, 2022, 07:35 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationMar 04, 2022 Option Exercise$3.677,40627,18038,942Mar 08, 2022, 07:35 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationMar 04, 2022 Sale$30.5021,710662,20832,232Mar 08, 2022, 07:35 PM
EMPFIELD JAMES R.EVP, Drug DiscoveryMar 04, 2022 Option Exercise$31.426,685210,04328,315Mar 08, 2022, 07:32 PM
EMPFIELD JAMES R.EVP, Drug DiscoveryMar 07, 2022 Option Exercise$30.239,647291,62942,853Mar 08, 2022, 07:32 PM
EMPFIELD JAMES R.EVP, Drug DiscoveryMar 07, 2022 Option Exercise$6.8642,500291,40051,805Mar 08, 2022, 07:32 PM
EMPFIELD JAMES R.EVP, Drug DiscoveryMar 04, 2022 Option Exercise$8.4025,000210,00035,000Mar 08, 2022, 07:32 PM
EMPFIELD JAMES R.EVP, Drug DiscoveryMar 04, 2022 Sale$30.7918,315563,91910,000Mar 08, 2022, 07:32 PM
EMPFIELD JAMES R.EVP, Drug DiscoveryMar 07, 2022 Sale$30.5432,8531,003,47541,048Mar 08, 2022, 07:32 PM
KENNEY CHRISTOPHER JOHNChief Medical OfficerJan 21, 2022 Buy$28.8170020,167700Jan 21, 2022, 05:04 PM
AZAB MOHAMMADDirectorDec 15, 2021 Option Exercise$3.673,08611,32666,819Dec 17, 2021, 04:04 PM
PATOU GARYDirectorDec 08, 2021 Option Exercise$3.672,0577,54925,630Dec 10, 2021, 04:20 PM
Von Seggern ChristopherChief Commercial OfficerDec 06, 2021 Buy$24.404,00097,6004,000Dec 07, 2021, 04:13 PM
PIMSTONE SIMON N.DirectorNov 15, 2021 Sale$31.3317,557550,061210,186Nov 16, 2021, 08:40 PM
PATOU GARYDirectorMar 17, 2021 Option Exercise$19.491001,949100Jun 04, 2021, 07:20 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationMay 28, 2021 Option Exercise$18.914,21679,72538,299Jun 01, 2021, 04:11 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationMay 28, 2021 Option Exercise$3.8125,71997,90740,491Jun 01, 2021, 04:11 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationMay 28, 2021 Sale$18.816,067114,12035,144Jun 01, 2021, 04:11 PM
PIMSTONE SIMON N.CEOMay 24, 2021 Option Exercise$19.175,07697,307227,743May 26, 2021, 04:11 PM
PIMSTONE SIMON N.CEOMay 24, 2021 Option Exercise$3.7622,63385,100232,819May 26, 2021, 04:11 PM
Hayden Michael RDirectorFeb 18, 2021 Option Exercise$2.9341,152120,47292,076Feb 18, 2021, 05:59 PM
Hayden Michael RDirectorFeb 16, 2021 Option Exercise$2.685,14413,786112,706Feb 18, 2021, 05:59 PM
AZAB MOHAMMADDirectorDec 15, 2020 Option Exercise$3.763,08611,60363,733Dec 15, 2020, 04:39 PM
TARNOW MICHAEL MDirectorOct 28, 2020 Option Exercise$3.7610,28838,68380,001Oct 29, 2020, 04:27 PM
PATOU GARYDirectorOct 28, 2020 Option Exercise$3.762,0577,73423,573Oct 29, 2020, 04:20 PM
TARNOW MICHAEL MDirectorJun 09, 2020 Option Exercise$3.525,14418,10769,713Jun 10, 2020, 05:17 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationJun 01, 2020 Option Exercise$13.701,63022,33116,796Jun 02, 2020, 05:40 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationJun 01, 2020 Option Exercise$3.568,23029,29918,426Jun 02, 2020, 05:40 PM
HOLLER FRANK ADirectorMay 29, 2020 Option Exercise$3.563,08610,986122,041Jun 02, 2020, 04:54 PM
PIMSTONE SIMON N.CEOJun 01, 2020 Sale$14.433,00043,290255,186Jun 02, 2020, 04:50 PM
PIMSTONE SIMON N.CEOMay 29, 2020 Sale$13.995,00069,950258,186Jun 02, 2020, 04:50 PM
PIMSTONE SIMON N.CEOMay 26, 2020 Option Exercise$14.901,10816,509263,186May 28, 2020, 05:02 PM
PIMSTONE SIMON N.CEOMay 26, 2020 Option Exercise$3.566,17221,972264,294May 28, 2020, 05:02 PM
AZAB MOHAMMADDirectorDec 16, 2019 Option Exercise$3.563,08610,98660,647Dec 17, 2019, 05:04 PM
PATOU GARYDirectorDec 04, 2019 Option Exercise$3.562,0577,32321,516Dec 06, 2019, 05:12 PM
TARNOW MICHAEL MDirectorNov 21, 2019 Option Exercise$3.557,20125,53369,713Nov 22, 2019, 01:30 PM
PIMSTONE SIMON N.CEOSep 20, 2019 Sale$9.5110,39598,856258,122Sep 24, 2019, 06:14 PM
HOLLER FRANK ADirectorSep 20, 2019 Sale$9.395,20648,884118,955Sep 20, 2019, 04:15 PM
HOLLER FRANK ADirectorSep 19, 2019 Sale$9.277,60070,452124,161Sep 20, 2019, 04:15 PM
PIMSTONE SIMON N.CEOSep 17, 2019 Option Exercise$9.4417,230162,651268,517Sep 18, 2019, 07:06 PM
PIMSTONE SIMON N.CEOSep 17, 2019 Option Exercise$3.5357,612203,381272,209Sep 18, 2019, 07:06 PM
HOLLER FRANK ADirectorSep 18, 2019 Sale$9.284,36840,535131,761Sep 18, 2019, 06:43 PM
HOLLER FRANK ADirectorSep 17, 2019 Sale$9.325,06947,243136,129Sep 18, 2019, 06:43 PM
AZAB MOHAMMADDirectorSep 13, 2019 Sale$9.312321457,561Sep 17, 2019, 04:46 PM
HOLLER FRANK ADirectorSep 12, 2019 Option Exercise$9.389,64990,508141,198Sep 13, 2019, 08:13 PM
HOLLER FRANK ADirectorSep 12, 2019 Option Exercise$3.0731,89298,052148,979Sep 13, 2019, 08:13 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationSep 12, 2019 Option Exercise$9.381,86817,52210,196Sep 13, 2019, 06:58 PM
ROBIN SHERRINGTONEVP, Strategy & InnovationSep 12, 2019 Option Exercise$3.076,17218,94812,064Sep 13, 2019, 06:58 PM
TARNOW MICHAEL MDirectorMay 21, 2019 Option Exercise$3.212,0576,60364,569May 23, 2019, 11:56 AM
Hayden Michael RDirectorMar 19, 2019 Option Exercise$3.3820,57669,54750,924Mar 20, 2019, 05:13 PM
PATOU GARYDirectorDec 14, 2018 Option Exercise$3.072,0576,31519,459Dec 18, 2018, 04:06 PM
COHEN CHARLES J.VP, BiologyDec 11, 2018 Option Exercise$7.001,64411,5086,550Dec 13, 2018, 01:56 PM
COHEN CHARLES J.VP, BiologyDec 11, 2018 Option Exercise$3.074,11512,6338,194Dec 13, 2018, 01:56 PM
AZAB MOHAMMADDirectorDec 06, 2018 Option Exercise$3.073,0869,47457,584Dec 10, 2018, 09:10 PM
TARNOW MICHAEL MDirectorJun 21, 2018 Option Exercise$3.4312,34542,35467,512Jun 22, 2018, 04:40 PM
AZAB MOHAMMADDirectorJun 21, 2018 Option Exercise$3.7010,28838,06654,498Jun 22, 2018, 04:39 PM
PATOU GARYDirectorJun 14, 2018 Option Exercise$8.302,85623,70517,402Jun 15, 2018, 07:32 PM
PATOU GARYDirectorJun 14, 2018 Option Exercise$3.708,23030,45120,258Jun 15, 2018, 07:32 PM
ROBIN SHERRINGTONEVP Bus. & Corp. DevelopmentMar 15, 2018 Option Exercise$4.631,9288,9175,892Mar 16, 2018, 04:33 PM
ROBIN SHERRINGTONEVP Bus. & Corp. DevelopmentMar 15, 2018 Option Exercise$3.773,08611,6347,820Mar 16, 2018, 04:33 PM
HOLLER FRANK ADirectorMar 14, 2018 Option Exercise$3.773,08611,634118,955Mar 16, 2018, 04:23 PM
PIMSTONE SIMON N.CEOMar 12, 2018 Option Exercise$3.7710,28838,786228,135Mar 14, 2018, 04:52 PM
COHEN CHARLES J.VP, BiologyFeb 12, 2018 Option Exercise$3.5022,66979,3424,079Feb 14, 2018, 05:55 PM
COHEN CHARLES J.VP, BiologyFeb 12, 2018 Option Exercise$3.7126,74899,23526,748Feb 14, 2018, 05:55 PM
AZAB MOHAMMADDirectorNov 15, 2017 Buy$2.2215,00033,28044,210Nov 16, 2017, 04:56 PM
AZAB MOHAMMADDirectorSep 22, 2017 Buy$2.958,00023,60029,210Sep 25, 2017, 05:00 PM
AZAB MOHAMMADDirectorSep 21, 2017 Buy$2.952,0005,90021,210Sep 25, 2017, 05:00 PM
AZAB MOHAMMADDirectorAug 18, 2017 Buy$2.906,31218,30219,210Aug 21, 2017, 04:49 PM
AZAB MOHAMMADDirectorAug 17, 2017 Buy$2.65236112,898Aug 21, 2017, 04:49 PM
WINQUIST RAYMONDHead, Translational ResearchAug 18, 2017 Buy$2.991,0002,9951,000Aug 21, 2017, 04:48 PM
EMPFIELD JAMES R.SVP, Drug DiscoveryAug 15, 2017 Buy$2.4810,00024,82410,000Aug 17, 2017, 05:33 PM
BVF PARTNERS L P/IL10% OwnerAug 15, 2017 Buy$2.4118,85845,4891,674,468Aug 16, 2017, 06:55 PM
BVF PARTNERS L P/IL10% OwnerAug 14, 2017 Buy$2.7041,344111,7781,663,039Aug 16, 2017, 06:55 PM
Svoronos DawnDirectorAug 14, 2017 Buy$2.8250,000140,77050,000Aug 15, 2017, 04:54 PM
PATOU GARYDirectorAug 10, 2017 Buy$2.787,50020,83612,500Aug 14, 2017, 06:07 PM
MORTIMER IANCFO & COOAug 10, 2017 Buy$2.9010,00029,00014,300Aug 14, 2017, 06:07 PM
MORTIMER IANCFO & COOAug 10, 2017 Buy$2.855,00014,2256,000Aug 14, 2017, 06:07 PM
SCHELLER RICHARD HDirectorAug 10, 2017 Buy$2.857,00019,9507,000Aug 14, 2017, 06:07 PM
PIMSTONE SIMON N.President & CEOAug 10, 2017 Buy$2.906,00017,400217,847Aug 14, 2017, 06:06 PM
Hayden Michael RDirectorAug 14, 2017 Buy$2.7515,00041,247161,187Aug 14, 2017, 06:06 PM
GANNON STEVENDirectorAug 11, 2017 Buy$2.8215,00042,26715,000Aug 14, 2017, 06:05 PM
PATOU GARYDirectorAug 08, 2017 Buy$3.005,00015,0025,000Aug 10, 2017, 07:58 PM
BVF PARTNERS L P/IL10% OwnerJun 27, 2017 Buy$3.0485,461259,4681,635,032Jun 30, 2017, 12:00 PM
BVF PARTNERS L P/IL10% OwnerJun 27, 2017 Buy$4.0085,461341,8441,635,032Jun 29, 2017, 06:21 PM
BVF PARTNERS L P/IL10% OwnerJun 22, 2017 Buy$4.008,26333,0521,588,237Jun 23, 2017, 07:16 PM
BVF PARTNERS L P/IL10% OwnerJun 21, 2017 Buy$4.0012,14848,5921,583,712Jun 23, 2017, 07:16 PM
TARNOW MICHAEL MDirectorJun 19, 2017 Option Exercise$3.511,0283,60856,195Jun 20, 2017, 04:37 PM
BVF PARTNERS L P/IL10% OwnerJun 16, 2017 Buy$3.8511,03442,4811,575,365Jun 19, 2017, 07:33 PM
BVF PARTNERS L P/IL10% OwnerJun 15, 2017 Buy$3.8411,77945,1961,569,268Jun 19, 2017, 07:33 PM
BVF PARTNERS L P/IL10% OwnerJun 19, 2017 Buy$3.853,59513,8411,577,332Jun 19, 2017, 07:33 PM
BVF PARTNERS L P/IL10% OwnerJun 07, 2017 Buy$3.85207,789800,2371,562,494Jun 08, 2017, 06:58 PM
BVF PARTNERS L P/IL10% OwnerJun 06, 2017 Buy$3.75150,909565,9091,449,048Jun 08, 2017, 06:58 PM
ROBIN SHERRINGTONSVP Bus. & Corp. DevelopmentMay 12, 2017 Option Exercise$4.181,3455,6224,734May 16, 2017, 04:32 PM
ROBIN SHERRINGTONSVP Bus. & Corp. DevelopmentMay 12, 2017 Option Exercise$3.212,0576,6036,079May 16, 2017, 04:32 PM
Hayden Michael RDirectorMar 14, 2017 Option Exercise$3.4411,83040,71130,348Mar 15, 2017, 07:53 PM
Hayden Michael RDirectorMar 14, 2017 Option Exercise$3.7348,868182,200146,187Mar 15, 2017, 07:53 PM
HOLLER FRANK ADirectorDec 15, 2016 Sale$7.8530,000235,500115,869Dec 19, 2016, 05:07 PM
TARNOW MICHAEL MDirectorDec 12, 2016 Option Exercise$3.2114,40346,23469,570Dec 13, 2016, 04:57 PM
PATOU GARYDirectorDec 06, 2016 Option Exercise$7.904,40334,78412,028Dec 08, 2016, 04:52 PM
PATOU GARYDirectorDec 06, 2016 Option Exercise$3.2112,34539,62716,431Dec 08, 2016, 04:52 PM
AZAB MOHAMMADDirectorDec 01, 2016 Option Exercise$7.804,40834,38212,875Dec 02, 2016, 06:05 PM
AZAB MOHAMMADDirectorDec 01, 2016 Option Exercise$3.2112,34539,62717,283Dec 02, 2016, 06:05 PM
HOLLER FRANK ADirectorAug 19, 2016 Sale$7.6511,93891,338145,869Aug 23, 2016, 04:51 PM
HOLLER FRANK ADirectorAug 18, 2016 Sale$7.709,59973,912157,807Aug 18, 2016, 08:24 PM
HOLLER FRANK ADirectorAug 17, 2016 Sale$7.891,60012,624167,406Aug 18, 2016, 08:24 PM
HOLLER FRANK ADirectorAug 16, 2016 Sale$8.256,86356,620169,006Aug 18, 2016, 08:24 PM
PIMSTONE SIMON N.President & CEOJul 29, 2016 Option Exercise$7.464,70335,084211,847Aug 02, 2016, 05:10 PM
PIMSTONE SIMON N.President & CEOJul 29, 2016 Option Exercise$3.3012,34540,738216,550Aug 02, 2016, 05:10 PM
MORTIMER IANCFO & COOJun 24, 2016 Buy$6.234,30026,7904,300Jun 28, 2016, 04:41 PM
MORTIMER IANCFO & COOJun 24, 2016 Buy$6.151,0006,1501,000Jun 28, 2016, 04:41 PM
Hayden Michael RDirectorMay 25, 2016 Option Exercise$3.308,23027,15918,518May 27, 2016, 05:07 PM
TARNOW MICHAEL MDirectorApr 28, 2016 Option Exercise$3.351,5435,16956,710Apr 29, 2016, 06:12 PM
ROBIN SHERRINGTONSVP Bus. & Corp. DevelopmentDec 16, 2015 Option Exercise$7.942291,8184,022Dec 21, 2015, 06:06 AM
ROBIN SHERRINGTONSVP Bus. & Corp. DevelopmentDec 16, 2015 Option Exercise$5.224112,1454,251Dec 21, 2015, 06:06 AM
AZAB MOHAMMADDirectorDec 11, 2015 Option Exercise$5.222,46912,8884,938Dec 14, 2015, 05:37 PM
HOLLER FRANK ADirectorNov 24, 2015 Option Exercise$9.399959,343175,869Nov 25, 2015, 03:50 PM
HOLLER FRANK ADirectorNov 24, 2015 Option Exercise$5.222,05710,738176,864Nov 25, 2015, 03:50 PM
PATOU GARYDirectorNov 04, 2015 Option Exercise$8.321,95516,2664,086Nov 06, 2015, 05:20 PM
PATOU GARYDirectorNov 04, 2015 Option Exercise$5.223,49718,2546,041Nov 06, 2015, 05:20 PM
TARNOW MICHAEL MDirectorNov 02, 2015 Option Exercise$5.225,04126,31460,208Nov 04, 2015, 06:43 PM
GOLDBERG Y. PAULVP of Clinical DevelopmentSep 22, 2015 Option Exercise$9.538,34279,49928,149Sep 24, 2015, 09:56 PM
GOLDBERG Y. PAULVP of Clinical DevelopmentSep 22, 2015 Option Exercise$3.2430,38898,51329,218Sep 24, 2015, 09:56 PM
GOLDBERG Y. PAULVP of Clinical DevelopmentSep 24, 2015 Sale$8.6012,000103,2006,000Sep 24, 2015, 09:56 PM
GOLDBERG Y. PAULVP of Clinical DevelopmentSep 23, 2015 Sale$9.024,00036,08018,000Sep 24, 2015, 09:56 PM
GOLDBERG Y. PAULVP of Clinical DevelopmentSep 22, 2015 Sale$9.336,14957,38422,000Sep 24, 2015, 09:56 PM
ROBIN SHERRINGTONSVP Bus. & Corp. DevelopmentAug 18, 2015 Option Exercise$11.001,30214,3223,840Aug 20, 2015, 01:13 PM
ROBIN SHERRINGTONSVP Bus. & Corp. DevelopmentAug 18, 2015 Option Exercise$4.923,08515,1894,708Aug 20, 2015, 01:13 PM
PIMSTONE SIMON N.President & CEOAug 18, 2015 Option Exercise$11.008,67895,458204,205Aug 20, 2015, 01:11 PM
PIMSTONE SIMON N.President & CEOAug 18, 2015 Option Exercise$4.9420,576101,594210,713Aug 20, 2015, 01:11 PM
HOLLER FRANK ADirectorAug 18, 2015 Option Exercise$11.008689,548174,807Aug 20, 2015, 01:08 PM
HOLLER FRANK ADirectorAug 18, 2015 Option Exercise$4.982,05710,244175,675Aug 20, 2015, 01:08 PM
GOLDBERG Y. PAULVP of Clinical DevelopmentAug 18, 2015 Option Exercise$11.001,30214,3226,103Aug 20, 2015, 01:04 PM
GOLDBERG Y. PAULVP of Clinical DevelopmentAug 18, 2015 Option Exercise$4.923,08515,1896,971Aug 20, 2015, 01:04 PM
TARNOW MICHAEL MDirectorJun 17, 2015 Option Exercise$4.951,5437,63855,167Jun 19, 2015, 04:31 PM
Hayden Michael RDirectorFeb 03, 2015 Option Exercise$4.815,14424,74310,288Feb 05, 2015, 06:09 PM
PATOU GARYDirectorJan 07, 2015 Option Exercise$22.2895321,2332,544Jan 21, 2015, 08:13 PM
PATOU GARYDirectorJan 07, 2015 Option Exercise$4.983,49717,4153,497Jan 21, 2015, 08:13 PM
TARNOW MICHAEL MDirectorJan 08, 2015 Option Exercise$4.985,04125,10453,624Jan 12, 2015, 07:08 PM
Hayden Michael RDirectorJan 08, 2015 Option Exercise$4.985,14425,6175,144Jan 12, 2015, 07:06 PM
AZAB MOHAMMADDirectorJan 08, 2015 Option Exercise$4.982,46912,2962,469Jan 12, 2015, 07:04 PM
PATOU GARYDirectorJan 07, 2015 Option Exercise$4.983,49717,4153,497Jan 09, 2015, 08:30 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
GAROFALO ELIZABETH A.Director03/08/202464,993
GAROFALO ELIZABETH A.Director03/08/202464,960
GAROFALO ELIZABETH A.Director03/08/202495,583
ROBIN SHERRINGTONEVP, Strategy & Innovation03/07/202469,124
ROBIN SHERRINGTONEVP, Strategy & Innovation03/07/202485,114
ROBIN SHERRINGTONEVP, Strategy & Innovation03/07/2024330,290
GANNON STEVENDirector03/07/2024601,615
AZAB MOHAMMADDirector12/19/202342,552
PATOU GARYDirector12/14/2023311,898
PATOU GARYDirector12/13/2023119,913
PATOU GARYDirector12/13/2023137,487
PATOU GARYDirector12/13/2023311,898
PATOU GARYDirector12/13/2023447,085
Svoronos DawnDirector08/24/2023967,500
PIMSTONE SIMON N.Director05/31/20231,124,586
PIMSTONE SIMON N.Director06/01/2023870,971
PIMSTONE SIMON N.Director06/01/2023870,855
PIMSTONE SIMON N.Director05/31/20231,181,875
PIMSTONE SIMON N.Director05/31/20232,420,051
PIMSTONE SIMON N.Director05/30/20231,453,672
PIMSTONE SIMON N.Director06/01/20231,231,247
MORTIMER IANPRESIDENT & CEO05/24/2023518,105
MORTIMER IANPRESIDENT & CEO05/24/2023665,536
MORTIMER IANPRESIDENT & CEO05/24/20231,310,931
KENNEY CHRISTOPHER JOHNChief Medical Officer03/24/202324,507
PIMSTONE SIMON N.Director03/07/2023140,277
PIMSTONE SIMON N.Director03/07/2023190,225
PIMSTONE SIMON N.Director03/07/2023711,199
AZAB MOHAMMADDirector12/12/20228,270
PATOU GARYDirector11/25/20224,124
PATOU GARYDirector11/25/20225,513
PATOU GARYDirector11/25/202267,390
PATOU GARYDirector11/23/202270,610
AULIN SHERRYChief Financial Officer09/02/2022130,172
AULIN SHERRYChief Financial Officer09/02/2022130,061
AULIN SHERRYChief Financial Officer09/02/2022607,597
ROBIN SHERRINGTONEVP, Strategy & Innovation09/01/2022237,556
ROBIN SHERRINGTONEVP, Strategy & Innovation08/31/202259,516
ROBIN SHERRINGTONEVP, Strategy & Innovation08/31/202270,443
ROBIN SHERRINGTONEVP, Strategy & Innovation09/01/2022237,500
ROBIN SHERRINGTONEVP, Strategy & Innovation09/01/20221,675,476
ROBIN SHERRINGTONEVP, Strategy & Innovation08/31/2022823,547
EMPFIELD JAMES R.EVP, Drug Discovery08/12/2022275,911
EMPFIELD JAMES R.EVP, Drug Discovery08/12/2022275,750
EMPFIELD JAMES R.EVP, Drug Discovery08/12/20222,211,979
PIMSTONE SIMON N.Director08/16/20222,004,901
PIMSTONE SIMON N.Director08/15/20221,281,650
PIMSTONE SIMON N.Director08/12/20223,488,598
PIMSTONE SIMON N.Director03/08/202277,000
PIMSTONE SIMON N.Director03/04/202230,257
PIMSTONE SIMON N.Director03/07/202260,158
PIMSTONE SIMON N.Director03/04/202237,757
PIMSTONE SIMON N.Director03/07/202275,514
PIMSTONE SIMON N.Director03/08/2022375,636
PIMSTONE SIMON N.Director03/07/2022948,260
PIMSTONE SIMON N.Director03/04/2022285,425
ROBIN SHERRINGTONEVP, Strategy & Innovation03/04/202221,868
ROBIN SHERRINGTONEVP, Strategy & Innovation03/04/202227,180
ROBIN SHERRINGTONEVP, Strategy & Innovation03/04/2022662,208
EMPFIELD JAMES R.EVP, Drug Discovery03/04/2022210,043
EMPFIELD JAMES R.EVP, Drug Discovery03/07/2022291,629
EMPFIELD JAMES R.EVP, Drug Discovery03/07/2022291,400
EMPFIELD JAMES R.EVP, Drug Discovery03/04/2022210,000
EMPFIELD JAMES R.EVP, Drug Discovery03/04/2022563,919
EMPFIELD JAMES R.EVP, Drug Discovery03/07/20221,003,475
KENNEY CHRISTOPHER JOHNChief Medical Officer01/21/202220,167
AZAB MOHAMMADDirector12/15/202111,326
PATOU GARYDirector12/08/20217,549
Von Seggern ChristopherChief Commercial Officer12/06/202197,600
PIMSTONE SIMON N.Director11/15/2021550,061
PATOU GARYDirector03/17/20211,949
ROBIN SHERRINGTONEVP, Strategy & Innovation05/28/202179,725
ROBIN SHERRINGTONEVP, Strategy & Innovation05/28/202197,907
ROBIN SHERRINGTONEVP, Strategy & Innovation05/28/2021114,120
PIMSTONE SIMON N.CEO05/24/202197,307
PIMSTONE SIMON N.CEO05/24/202185,100
Hayden Michael RDirector02/18/2021120,472
Hayden Michael RDirector02/16/202113,786
AZAB MOHAMMADDirector12/15/202011,603
TARNOW MICHAEL MDirector10/28/202038,683
PATOU GARYDirector10/28/20207,734
TARNOW MICHAEL MDirector06/09/202018,107
ROBIN SHERRINGTONEVP, Strategy & Innovation06/01/202022,331
ROBIN SHERRINGTONEVP, Strategy & Innovation06/01/202029,299
HOLLER FRANK ADirector05/29/202010,986
PIMSTONE SIMON N.CEO06/01/202043,290
PIMSTONE SIMON N.CEO05/29/202069,950
PIMSTONE SIMON N.CEO05/26/202016,509
PIMSTONE SIMON N.CEO05/26/202021,972
AZAB MOHAMMADDirector12/16/201910,986
PATOU GARYDirector12/04/20197,323
TARNOW MICHAEL MDirector11/21/201925,533
PIMSTONE SIMON N.CEO09/20/201998,856
HOLLER FRANK ADirector09/20/201948,884
HOLLER FRANK ADirector09/19/201970,452
PIMSTONE SIMON N.CEO09/17/2019162,651
PIMSTONE SIMON N.CEO09/17/2019203,381
HOLLER FRANK ADirector09/18/201940,535
HOLLER FRANK ADirector09/17/201947,243
AZAB MOHAMMADDirector09/13/2019214
HOLLER FRANK ADirector09/12/201990,508
HOLLER FRANK ADirector09/12/201998,052
ROBIN SHERRINGTONEVP, Strategy & Innovation09/12/201917,522
ROBIN SHERRINGTONEVP, Strategy & Innovation09/12/201918,948
TARNOW MICHAEL MDirector05/21/20196,603
Hayden Michael RDirector03/19/201969,547
PATOU GARYDirector12/14/20186,315
COHEN CHARLES J.VP, Biology12/11/201811,508
COHEN CHARLES J.VP, Biology12/11/201812,633
AZAB MOHAMMADDirector12/06/20189,474
TARNOW MICHAEL MDirector06/21/201842,354
AZAB MOHAMMADDirector06/21/201838,066
PATOU GARYDirector06/14/201823,705
PATOU GARYDirector06/14/201830,451
ROBIN SHERRINGTONEVP Bus. & Corp. Development03/15/20188,917
ROBIN SHERRINGTONEVP Bus. & Corp. Development03/15/201811,634
HOLLER FRANK ADirector03/14/201811,634
PIMSTONE SIMON N.CEO03/12/201838,786
COHEN CHARLES J.VP, Biology02/12/201879,342
COHEN CHARLES J.VP, Biology02/12/201899,235
AZAB MOHAMMADDirector11/15/201733,280
AZAB MOHAMMADDirector09/22/201723,600
AZAB MOHAMMADDirector09/21/20175,900
AZAB MOHAMMADDirector08/18/201718,302
AZAB MOHAMMADDirector08/17/201761
WINQUIST RAYMONDHead, Translational Research08/18/20172,995
EMPFIELD JAMES R.SVP, Drug Discovery08/15/201724,824
BVF PARTNERS L P/IL10% Owner08/15/201745,489
BVF PARTNERS L P/IL10% Owner08/14/2017111,778
Svoronos DawnDirector08/14/2017140,770
PATOU GARYDirector08/10/201720,836
MORTIMER IANCFO & COO08/10/201729,000
MORTIMER IANCFO & COO08/10/201714,225
SCHELLER RICHARD HDirector08/10/201719,950
PIMSTONE SIMON N.President & CEO08/10/201717,400
Hayden Michael RDirector08/14/201741,247
GANNON STEVENDirector08/11/201742,267
PATOU GARYDirector08/08/201715,002
BVF PARTNERS L P/IL10% Owner06/27/2017259,468
BVF PARTNERS L P/IL10% Owner06/27/2017341,844
BVF PARTNERS L P/IL10% Owner06/22/201733,052
BVF PARTNERS L P/IL10% Owner06/21/201748,592
TARNOW MICHAEL MDirector06/19/20173,608
BVF PARTNERS L P/IL10% Owner06/16/201742,481
BVF PARTNERS L P/IL10% Owner06/15/201745,196
BVF PARTNERS L P/IL10% Owner06/19/201713,841
BVF PARTNERS L P/IL10% Owner06/07/2017800,237
BVF PARTNERS L P/IL10% Owner06/06/2017565,909
ROBIN SHERRINGTONSVP Bus. & Corp. Development05/12/20175,622
ROBIN SHERRINGTONSVP Bus. & Corp. Development05/12/20176,603
Hayden Michael RDirector03/14/201740,711
Hayden Michael RDirector03/14/2017182,200
HOLLER FRANK ADirector12/15/2016235,500
TARNOW MICHAEL MDirector12/12/201646,234
PATOU GARYDirector12/06/201634,784
PATOU GARYDirector12/06/201639,627
AZAB MOHAMMADDirector12/01/201634,382
AZAB MOHAMMADDirector12/01/201639,627
HOLLER FRANK ADirector08/19/201691,338
HOLLER FRANK ADirector08/18/201673,912
HOLLER FRANK ADirector08/17/201612,624
HOLLER FRANK ADirector08/16/201656,620
PIMSTONE SIMON N.President & CEO07/29/201635,084
PIMSTONE SIMON N.President & CEO07/29/201640,738
MORTIMER IANCFO & COO06/24/201626,790
MORTIMER IANCFO & COO06/24/20166,150
Hayden Michael RDirector05/25/201627,159
TARNOW MICHAEL MDirector04/28/20165,169
ROBIN SHERRINGTONSVP Bus. & Corp. Development12/16/20151,818
ROBIN SHERRINGTONSVP Bus. & Corp. Development12/16/20152,145
AZAB MOHAMMADDirector12/11/201512,888
HOLLER FRANK ADirector11/24/20159,343
HOLLER FRANK ADirector11/24/201510,738
PATOU GARYDirector11/04/201516,266
PATOU GARYDirector11/04/201518,254
TARNOW MICHAEL MDirector11/02/201526,314
GOLDBERG Y. PAULVP of Clinical Development09/22/201579,499
GOLDBERG Y. PAULVP of Clinical Development09/22/201598,513
GOLDBERG Y. PAULVP of Clinical Development09/24/2015103,200
GOLDBERG Y. PAULVP of Clinical Development09/23/201536,080
GOLDBERG Y. PAULVP of Clinical Development09/22/201557,384
ROBIN SHERRINGTONSVP Bus. & Corp. Development08/18/201514,322
ROBIN SHERRINGTONSVP Bus. & Corp. Development08/18/201515,189
PIMSTONE SIMON N.President & CEO08/18/201595,458
PIMSTONE SIMON N.President & CEO08/18/2015101,594
HOLLER FRANK ADirector08/18/20159,548
HOLLER FRANK ADirector08/18/201510,244
GOLDBERG Y. PAULVP of Clinical Development08/18/201514,322
GOLDBERG Y. PAULVP of Clinical Development08/18/201515,189
TARNOW MICHAEL MDirector06/17/20157,638
Hayden Michael RDirector02/03/201524,743
PATOU GARYDirector01/07/201521,233
PATOU GARYDirector01/07/201517,415
TARNOW MICHAEL MDirector01/08/201525,104
Hayden Michael RDirector01/08/201525,617
AZAB MOHAMMADDirector01/08/201512,296
PATOU GARYDirector01/07/201517,415
Load More Insider Transactions
FUNDS WITH A POSITION IN XENON PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
DRIEHAUS CAPITAL MANAGEMENT LLC4,345,1802.41%-3.72%Growth
CAPITAL WORLD INVESTORS2,681,5370.02%17.87%Growth At A Reasonable Price
BLACKROCK INC.2,067,0630.00243%108.49%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.1,048,7250.1%90.68%Other
BAKER BROS. ADVISORS LP993,6790.52%32.2%Other
ORBIMED ADVISORS LLC550,0000.51%-42.64%Other
CANDRIAM S.C.A.530,8840.17%-6.84%Other
HOLOCENE ADVISORS, LP178,4700.03%ExitedGrowth At A Reasonable Price
BAMCO INC /NY/100,1000.01%No changeGrowth At A Reasonable Price
D. E. SHAW & CO., INC.84,1530.00339%107.54%Other
TIG ADVISORS, LLC64,200 (Call)0.37%NewEvent Driven
GEODE CAPITAL MANAGEMENT, LLC62,0730.0003%10.95%Other
ALPS ADVISORS INC50,7800.02%7.25%Other
UBS OCONNOR LLC14,6760.05%-69.85%Value
TUDOR INVESTMENT CORP ET AL43,2210.02%NewEvent Driven, Other
RENAISSANCE TECHNOLOGIES LLC32,6000.00232%48.86%Other
BALYASNY ASSET MANAGEMENT L.P.15,8510.00137%NewEvent Driven
CHANGE IN SHARES OUTSTANDING FOR XENON PHARMACEUTICALS INC
STOCK BUYBACKS FOR XENON PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0.21%
1Q
09/30/2023
03/31/2023
0.42%
2Q
09/30/2023
12/31/2022
0.52%
3Q
09/30/2023
09/30/2022
0.82%
4Q
09/30/2023
06/30/2022
17.46%
5Q
09/30/2023
03/31/2022
20.33%
6Q
09/30/2023
12/31/2021
51.29%
7Q
09/30/2023
09/30/2021
56.13%
8Q
09/30/2023
06/30/2021
56.81%
9Q
09/30/2023
03/31/2021
79.23%
10Q
09/30/2023
12/31/2020
88.55%
11Q
09/30/2023
09/30/2020
88.60%
12Q
09/30/2023
06/30/2020
88.69%
13Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0.21%
1Q
03/31/2023
0.42%
2Q
12/31/2022
0.52%
3Q
09/30/2022
0.82%
4Q
06/30/2022
17.46%
5Q
03/31/2022
20.33%
6Q
12/31/2021
51.29%
7Q
09/30/2021
56.13%
8Q
06/30/2021
56.81%
9Q
03/31/2021
79.23%
10Q
12/31/2020
88.55%
11Q
09/30/2020
88.60%
12Q
06/30/2020
88.69%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR XENON PHARMACEUTICALS INC
LOADING...